George Fisher

All Publications

• Late-Onset Immunotherapy-Induced Myocarditis 2 Years After Checkpoint Inhibitor Initiation JACC: CardioOncology Nguyen, A. T., Berry, G. J., Witteles, R. M., Le, D. T., Wu, S. M., Fisher, G. A., Zhu, H. 2022; 4 (5): 727–730

  View details for DOI 10.1016/j.jaccao.2022.04.007

  View details for PubMedCentralID PMC9830192

• Artificial intelligence-powered spatial analysis of tumor-infiltrating lymphocytes predicts survival after immune checkpoint inhibitor therapy across multiple cancer types. Journal of Clinical Oncology Shen, J., Lee, T., Hwang, J., Choi, Y., Lee, S., Kim, H., Chung, J., Bogdan, S., Huang, M., Raclin, T., Fisher, G. A., Pereira, S., Park, S., Ma, M., Yoo, D., Shin, S., Paeng, K., Ock, C., Mok, T., Bang, Y. 2021; 39

  View details for DOI 10.1200/JCO.2021.39.15_suppl.2607